Immediate Impact
2 from Science/Nature 65 standout
Citing Papers
Deciphering breast cancer: from biology to the clinic
2023 Standout
Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
2023 Standout
Works of Patrick Magill being referenced
Health-Related Quality-of-Life in a Randomized Phase III First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients from Asia with Advanced NSCLC (IPASS)
2011
Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II Study
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Patrick Magill | 474 | 346 | 179 | 191 | 12 | 662 | |
| R Gray | 434 | 265 | 309 | 155 | 15 | 721 | |
| Donald I. Twito | 356 | 229 | 168 | 173 | 13 | 593 | |
| P. Neven | 516 | 188 | 218 | 186 | 24 | 815 | |
| Kimberly B. Koenig | 501 | 195 | 464 | 155 | 15 | 837 | |
| Sally Garnett | 601 | 534 | 265 | 336 | 12 | 830 | |
| Lavina Bharwani | 482 | 171 | 148 | 286 | 13 | 841 | |
| Irene De Santo | 381 | 328 | 207 | 79 | 13 | 665 | |
| A McKinna | 403 | 124 | 228 | 208 | 14 | 749 | |
| JFR Robertson | 429 | 145 | 327 | 137 | 13 | 820 | |
| Addie Dvir | 325 | 367 | 303 | 176 | 25 | 778 |
All Works
Loading papers...